Search for: "EMA 3, Inc."
Results 1 - 20
of 26
Sorted by Relevance
|
Sort by Date
10 Nov 2014, 8:31 pm
Premium Nail Concepts, Inc., a case from the Montana Supreme Court, plaintiff operated a nail salon from 1998 to 2009. [read post]
25 Oct 2016, 1:22 am
In 2013, the EMA asked the MHRA to reinspect facilities at Roche in the UK and at its subsidiary, Genentech Inc., in the US. [read post]
5 Aug 2011, 2:27 pm
European Drug Regulator EMA Recommended New Actos Contra-Indications And Warnings In July 2011 (Posted by Tom Lamb at DrugInjuryWatch.com) On August 4, 2011 we learned that Takeda Pharmaceuticals America, Inc. had revised the prescribing information -- also called the package insert or label -- for its diabetes drug Actos (pioglitazone) and other anti-diabetic pioglitazone-containing medicines by means of this item, "FDA Drug Safety Communication: Updated drug labels for… [read post]
22 Jul 2011, 2:34 pm
" (8/4/11, Health Canada MedEffect e-Notice) Multaq (dronedarone), Sanofi-aventis Canada Inc., must not be prescribed to patients with permanent atrial fibrillation. [read post]
4 May 2020, 7:05 am
Friedlich, No. 11-21843, 2011 WL 13322791, at *3 (S.D. [read post]
22 Jul 2011, 6:18 pm
EMA (Alito, J). [read post]
4 Apr 2012, 9:12 am
EMA which clearly granted First Amendment protection to video games. [read post]
3 Nov 2014, 7:42 am
Nationwide, Inc., a Florida corporation, also doing business as EMA and Expense Management America; New Life Financial Solutions, Inc., a Florida corporation, also doing business as New Life Financial, and New Life Financial Services; 1UC Inc., a Wyoming corporation, also doing business as 1st United Consultants, and First United Consultants; 7242701 Canada Inc., a Canadian corporation; 7242697, Canada Inc., a Canadian corporation; 7246293,… [read post]
1 Dec 2011, 2:02 pm
(NYSE: WPI) today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration for its Abbreviated New Drug Application for Vestura(TM) (3 mg drospirenone and 0.02 mg ethinyl estradiol), a generic version of Bayer's Yaz(R) oral contraceptive product. [read post]
29 Jul 2011, 11:13 pm
Paddock Laboratories, Inc. / ?????????? [read post]
27 Jul 2011, 1:01 am
Paddock Laboratories, Inc. [read post]
10 Aug 2011, 4:30 am
(Patent Docs) Prezista (Darunavir) – US: Patent infringement complaint filed following a Paragraph IV certification: Tibotec Inc. et al. v. [read post]
8 Dec 2010, 2:20 am
Bulgarian Patent Office (Kluwer Patent Blog) Canada: World AIDS Day brings calls for legislative caution, reform (IP Watch) EU: EMA publishes guidelines for biosimilar antibodies (Part I – Patent Docs), (Part II – Patent Docs) EU: AstraZeneca and Nycomed raid by EU antitrust officials (GenericsWeb) India: Supreme Court dismisses Bayer’ petition in patent linkage matter (Generic Pharmaceuticals and IP) (Spicy IP) (GenericsWeb) (SiNApSE) India: Demand for changes in patent… [read post]
2 Jan 2012, 8:00 am
EMA THREsq: http://www.hollywoodreporter.com/thr-esq/supreme-court-strikes-down-california-205827 4. [read post]
29 Mar 2015, 5:52 am
Things such as defense attorney fees, IME and EMA charges, and vocational reassessment fees — See, Associated Home Health Agency, Inc. v. [read post]
19 Jul 2016, 6:07 pm
” 440.13(3)(i). [read post]
23 Jun 2009, 7:47 pm
Bryan has previously blogged about EMA,. or economically motivated adulteration. [read post]
22 Nov 2020, 5:43 pm
Hodor, thus limiting the scope of the EMA’s opinions regarding MMI, PIR, and restrictions to the Grade I ankle sprain only; (3) By virtue of the “120-Day Rule”, E/C has waived any right it may have had to contest that claimant’s injuries, as determined by Kenneth Hodor, M.D., including those revealed by the February 5, 2019 right ankle MRI, arose out of, and occurred within the course and scope of the claimant’s employment. [read post]
20 Nov 2020, 9:36 pm
Teco Energy, Inc. v. [read post]
